In addition, auto-neoantigen-specific T cells could be detected in the CD39+CD103+CD8+ TILs in 3 of 7 patients with low mutation burden CRC through whole-exome and transcriptome sequencing of inferred neo-antigenic epitopes from tumor and normal tissues (86). This evidence concerns the gene ENTPD1 and neoplasm.